Studying the pathogenesis of BCR-ABL+ leukemia in mice

Oncogene

Volumn 21, Issue 56 REV. ISS. 7, 2002, Pages 8643-8651

  Van Etten, Richard A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CML; Philadelphia chromosome; Retrovirus; Tyrosine kinase

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; FUSION GENE; GENE MUTATION; HISTOPATHOLOGY; IN VIVO STUDY; LEUKEMIA; LEUKEMOGENESIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; ONCOGENE; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0037049763     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206091     Document Type: Article

References (74)

1. Anderson SM and Mladenovic J. (1996). Blood, 87, 238-244.
2. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F and Hoglund M. (1997). Genes Chrom. Cancer, 20, 299-304.
3. Brunel V, Sainty D, Carbuccia N, Mozzicolacci M, Fernandez F, Simonetti J, Gabert J, Dubreuil P, Lafage-Pochitaloff M and Birg F. (1996). Leukemia, 10, 2003.
4. Carlesso N, Frank DA and Griffin JD. (1996). J. Exp. Med., 183, 811-820.
5. Chung S-W, Wong PMC, Durkin H, Wu Y-S and Petersen J. (1991). Proc. Natl. Acad. Sci. USA, 88, 1585-1589.
6. Cortez D, Reuther G and Pendergast AM. (1997). Oncogene, 15, 2333-2342.
7. Daley G and Baltimore D. (1988). Proc. Natl. Acad. Sci. USA, 85, 9312-9316.
8. Daley GQ, Van Etten RA and Baltimore D. (1990). Science, 247, 824-830.
9. Daley GQ, Van Etten RA and Baltimore D. (1991). Proc. Natl. Acad. Sci. USA, 88, 11335-11338.
10. Dickens M, Rogers J, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL and Davis RJ. (1997). Science, 277, 693-696.
11. Elefanty AG and Cory S. (1992). Mol. Cell. Biol., 12, 1755-1763.
12. Elefanty AG, Hariharan IK and Cory S. (1990). EMBO J., 9, 1069-1078.
13. Era T and Witte ON. (2000). Proc. Natl. Acad. Sci. USA, 97, 1737-1742.
14. Franz WM, Berger P and Wang JYJ. (1989). EMBO J., 8, 137-147.
15. Golub TR, Barker GF, Lovett M and Gilliland DG. (1994). Cell, 77, 307-316.
16. Golub TR, Goga A, Barker GF, Afar DEH, McLaughlin J, Bohlander SK, Rowley JD, Witte ON and Gilliland DG. (1996). Mol. Cell. Biol., 16, 4107-4116.
17. Groopman JE and Golde DW. (1981). Ann. Int. Med., 94, 95-107.
18. Gross AW and Ren R. (2000). Oncogene, 19, 6286-6296.
19. Han X, Wong PMC and Chung S-W. (1991). Proc. Natl. Acad. Sci. USA, 88, 10129-10133.
20. Hannemann JR, McManus DM, Kabarowski JHS and Wiedemann LW. (1998). Br. J. Haematol., 102, 475-485.
21. Hariharan IK, Adams JM and Cory S. (1988). Oncogene Res., 3, 387-399.
22. Ilaria RL and Van Etten RA. (1995). Blood, 86, 3897-3904.
23. Ilaria RL and Van Etten RA. (1996). J. Biol. Chem., 271, 31704-31710.
24. Jackson P and Baltimore D. (1989). EMBO J., 8, 449-456.
25. Jiang X, Lopez A, Holyoake T, Eaves A and Eaves C. (1999). Proc. Natl. Acad. Sci. USA, 96, 12804-12809.
26. Jousset C, Carron C, Boureux A, Quang CT, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O and Ghysdael J. (1997). EMBO J., 16, 69-82.
27. Kelliher MA, McLaughlin J, Witte ON and Rosenberg N. (1990). Proc. Natl. Acad. Sci. USA, 87, 6649-6653.
28. Kelly LM, Liu Q, Kutok JL, Williams IR, Boulton CL and Gilliland DG. (2002). Blood, 99, 310-318.
29. Kipreos ET and Wang JYJ. (1992). Science, 256, 382-385.
30. Laneuville P, Heisterkamp N and Groffen J. (1991). Oncogene, 6, 275-282.
31. Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG and Van Etten RA. (2001). Blood, 97, 1442-1450.
32. Li S, Ilaria RL, Million RP, Daley GQ and Van Etten RA. (1999). J. Exp. Med., 189, 1399-1412.
33. Liu J, Wu Y, Ma GZ, Lu D, Haataja L, Heisterkamp N, Groffen J and Arlinghaus RB. (1996). Mol. Cell. Biol., 16, 998-1005.
34. Lugo TG, Pendergast A, Muller AJ and Witte ON. (1990). Science, 247, 1079-1082.
35. Lugo TG and Witte ON. (1989). Mol. Cell. Biol., 9, 1263-1270.
36. Maru Y and Witte ON. (1991). Cell, 67, 459-468.
37. Mayer BJ, Jackson PK, Van Etten RA and Baltimore D. (1992). Mol. Cell. Biol., 12, 609-618.
38. McLaughlin J, Chianese E and Witte ON. (1987). Proc. Natl. Acad. Sci. USA, 84, 6558-6562.
39. McWhirter JR, Galasso DL and Wang JYJ. (1993). Mol. Cell. Biol., 13, 7587-7595.
40. McWhirter JR and Wang JYJ. (1993). EMBO J., 12, 1533-1546.
41. Million RP, Aster J, Gilliland DG and Van Etten RA. (2002). Blood, 99, 4568-4577.
42. Million RP and Van Etten RA. (2000). Blood, 96, 664-670.
43. Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B and Skorski T. (1999). J. Exp. Med., 189, 1229-1242.
44. Okuda K, Golub TG, Gilliland DG and Griffin JD. (1996). Oncogene, 13, 1147-1152.
45. Papadopoulos P, Ridge SA, Boucher CA, Stocking C and Wiedemann LM. (1995). Cancer Res., 55, 34-38.
46. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML and Baltimore D. (1998). Blood, 92, 3780-3792.
47. Pendergast AM, Gishizky ML, Havlik MH and Witte ON. (1993a). Mol. Cell. Biol., 13, 1728-1736.
48. Pendergast AM, Muller AJ, Havlik MH, Maru Y and Witte ON. (1991). Cell, 66, 161-171.
49. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J and Gishizky ML. (1993b). Cell, 75, 175-185.
50. Perlingeiro RC, Kyba M and Daley GQ. (2001). Development, 128, 4597-4604.
51. Peters DG, Klucher KM, Perlingeiro RC, Dessain SK, Koh EY and Daley GQ. (2001). Oncogene, 20, 2636-2646.
52. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R and Pawson T. (1994). EMBO J., 13, 764-773.
53. Raitano AB, Halpern JR, Hambuch TM and Sawyers CL. (1995). Proc. Natl. Acad. Sci. USA, 92, 11746-11750.
54. Ren R, Zheng SY and Baltimore D. (1994). Genes Dev., 8, 783-795.
55. Reuther JY, Reuther GW, Cortez D, Pendergast AM and Baldwin ASJ. (1998). Genes Dev., 12, 968-981.
56. Roumiantsev S, de Aos I, Varticovski L, Ilaria RL and Van Etten RA. (2001). Blood, 97, 4-13.
57. Sawyers CL, Callahan W and Witte ON. (1992). Cell, 70, 901-910.
58. Sawyers CL, McLaughlin J and Witte ON. (1995). J. Exp. Med., 181, 307-313.
59. Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Van Rompey L, Peeters P, Van Etten RA, Ilaria Jr R, Marynen P and Gilliland DG. (1998). EMBO J., 17, 5321-5333.
60. Scott ML, Van Etten RA, Daley GQ and Baltimore D. (1991). Proc. Natl. Acad. Sci. USA, 88, 6506-6510.
61. Shuai K, Halpern J, ten Hoeve J, Rao X and Sawyers CL. (1996). Oncogene, 13, 247-254.
62. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen S-C, Zon G, Gewirtz AM, Perussia B and Calabretta B. (1995a). Blood, 86, 726-736.
63. Skorski T, Nieborowska-Skorska M, Szczylik C, Kasnakaraj P, Perrotti D, Zon G, Gewirtz A, Perussia B and Calabretta B. (1995b). Cancer Res., 55, 2275-2278.
64. Tomasson MH, Sternberg DW, Williams IR, Carroll M, Cain D, Aster JC, Ilaria RL, Van Etten RA and Gilliland DG. (2000). J. Clin. Invest., 105, 423-432.
65. Tomasson MH, Williams IR, Li S, Kutok J, Gillessen S, Dranoff G, Van Etten RA and Gilliland DG. (2001). Blood, 97, 1435-1441.
66. Van Etten RA. (2001). Curr. Oncol. Rep., 3, 228-237.
67. Van Etten RA, Debnath J, Zhou H and Casasnovas JM. (1995). Oncogene, 10, 1977-1988.
68. Van Etten RA, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT and Janmey PA. (1994). J. Cell Biol., 124, 325-340.
69. van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B, van Roy N, Marynen P, de Paepe A, Slater R and Speleman F. (2001). Genes Chrom. Cancer, 30, 274-282.
70. Varticovski L, Daley G, Jackson P, Baltimore D and Cantley L. (1991). Mol. Cell. Biol., 11, 1107-1113.
71. Voss J, Posern G, Hannemann JR, Wiedemann LM, Turhan AG, Poirel H, Bernard O, Adermann K, Kardinal C and Feller SM. (2000). Oncogene, 19, 1684-1690.
72. Wen S-T, Jackson PK and Van Etten RA. (1996). EMBO J., 15, 1583-1595.
73. Wu Y, Liu J and Arlinghaus RB. (1998). Oncogene, 16, 141-146.
74. Zhang X and Ren R. (1998). Blood, 92, 3829-3840.